Dataset Information

The significance of post-translational removal of ?-DG-N in early stage endometrial cancer development.

ABSTRACT: Endometrial cancer is one of the most common gynecological malignancies affecting post-menopausal women, yet the underlying mechanisms are not well understood. Dystroglycan (DG) is a large glycoprotein, consisting of ?- and ?-subunits that are non-covalently associated with each other. Modifications to ?-DG have been linked to a variety of cancers, where the N-terminus of ?-DG (?-DG-N) is post-translationally removed by a furin-like enzyme. However, the functional significance of ?-DG-N removal is unknown. Our previous studies have established that the ?-DG cleavage enzyme furin is significantly up-regulated in endometrial cancer. This study aimed to investigate the importance of ?-DG-N removal in post-menopausal endometrial cancer. We demonstrated that ?-DG-N removal predominantly occurred in early stage endometrial cancer tissues, and that the cleaved ?-DG-N was significantly elevated in the uterine lavage of early grade endometrial cancer patients. Furthermore, ?-DG-N removal significantly decreased the tight junction integrity and polarity of the endometrial epithelial cells, promoting the loss of polarity markers scribble and atypical protein kinase C (aPKC) and reducing the trans-epithelial electrical resistance. The removal of ?-DG-N also sensitized the cells for estrogen-dependent proliferation. These results strongly suggest that ?-DG-N removal plays an important role in early stage development of endometrial cancer, and that the elevated levels of ?-DG-N in uterine fluid may provide a biomarker for early detection of endometrial cancer.

SUBMITTER: Heng S

PROVIDER: S-EPMC5669861 | biostudies-other | 2017 Oct

REPOSITORIES: biostudies-other

ACCESS DATA

Publications

The significance of post-translational removal of α-DG-N in early stage endometrial cancer development.

Heng Sophea S Evans Jemma J Salamonsen Lois A LA Jobling Tom W TW Nie Guiying G

Oncotarget 20170420 47

Endometrial cancer is one of the most common gynecological malignancies affecting post-menopausal women, yet the underlying mechanisms are not well understood. Dystroglycan (DG) is a large glycoprotein, consisting of α- and β-subunits that are non-covalently associated with each other. Modifications to α-DG have been linked to a variety of cancers, where the N-terminus of α-DG (α-DG-N) is post-translationally removed by a furin-like enzyme. However, the functional significance of α-DG-N removal ...[more]

PMID: 29137235

Similar Datasets

Project description:Purpose: To evaluate the recurrent patterns and effect of clinicopathological factors on survival after recurrence (R-OS) in early stage endometrial cancer (EC). Methods: Patients with FIGO stage I-II EC, who underwent post-surgery radiotherapy (RT) at our institution between 2000 and 2017, were enrolled. First recurrent patterns, overall survival (OS), and R-OS were evaluated. Univariate and multivariate analyses (MVA) were used to evaluate factors associated with R-OS. Results: 756 patients were analyzed including 510 patients who received vaginal brachytherapy (VBT) and 246 patients who received external beam radiotherapy (EBRT) ± VBT, of whom 66 patients experienced recurrence, including 21 locoregional relapses and 45 distant metastases. Outside RT field recurrence predominated intra-RT field recurrence (106 versus 10 lesions). The 5-year OS rates for patients with and without recurrence were 62.2% and 98.2%, respectively (p<0.001). Among patients who underwent previous VBT, the 5-year OS rates were 61.1%, 92.3%, and 99.1% for distant metastasis, locoregional relapse, and non-recurrence, respectively (p<0.001); among patients who received EBRT ± VBT, the 5-year OS rates were 51.4%, 50.0%, and 98.3%, respectively (p<0.001).On Cox MVA of R-OS for locoregional recurrence patients, para-aortic lymph node metastasis was associated with poorer R-OS (hazard ratio [HR] 10.047, p=0.039), and salvage RT was superior to other therapies (HR 0.06, p=0.026). On Cox MVA of R-OS for distant metastasis, patients with brain metastasis (p=0.041) had the worst R-OS and patients benefited most from combined therapy (HR 0.02, p=0.001). Conclusion: Recurrent patterns were dominated by outside RT field and distant metastasis for early-stage ECs after adjuvant RT. The modality of prior RT had an impact on the choice of salvage therapy. RT could still be an effective salvage treatment for patients who develop locoregional recurrence. Patients with distant metastasis may benefit from combined therapies.

Dataset Information

The significance of post-translational removal of ?-DG-N in early stage endometrial cancer development.

Publications

The significance of post-translational removal of α-DG-N in early stage endometrial cancer development.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure